| Name | Title | Contact Details |
|---|
NMHC is a Port Washington, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Progressive Nursing Staffers is a Novi, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthReveal is a clinical AI company dedicated to improving outcomes and quality of life for patients with chronic disease by enabling clinicians to deliver the most effective evidence-based treatments tailored to each patient’s unique circumstances, every time. By using machine learning and bridging each patient’s information with the latest medical guidelines, we predict individual patient health risks and disease progression and prescribe individual treatment interventions to mitigate risks, improve quality and reduce costs.
Winchester Convalescent Hosp is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.